Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/23498Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Rasalkar, A A | - |
| dc.contributor.author | Salunke, B K | - |
| dc.contributor.author | Sayyed, R Z | - |
| dc.contributor.author | Chaudhari, A B | - |
| dc.contributor.author | Chincholkar, S B | - |
| dc.date.accessioned | 2013-11-13T04:44:01Z | - |
| dc.date.available | 2013-11-13T04:44:01Z | - |
| dc.date.issued | 2002-08 | - |
| dc.identifier.issn | 0975-1009 (Online); 0019-5189 (Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/23498 | - |
| dc.description | 930-933 | en_US |
| dc.description.abstract | Biotransformation of rifamycin B to rifamycin S using two strains of C. lunata namely NCIM 716 and NMU grown on various solid substrates viz., grass, paper, jowar/wheat straw, bran and bagasse was studied. Almost complete biotransformation efficiency of rifamycin B at 0.06mM concentration was observed within 24 hr. Among these two strains, C. lunata NMU showed 90% of biotransformation and higher rate of cellulose utilization on solid substrates vis-à-vis reference strain. Cellulase activity of both strains was also studied for exoglucanase, endoglucanase and β-glucosidase. Column bioreactor studies with bagasse revealed further improvement in biotransformation efficiency of C. lunota NMU. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.rights |  CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | IJEB Vol.40(08) [August 2002] | en_US |
| dc.title | Solid state cultivation of Curvularia lunata for transformation of rifamycin B to S | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJEB Vol.40(08) [August 2002] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJEB 40(8) 930-933.pdf | 949.36 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.